$127 Million is the total value of Stanley Capital Management, LLC's 35 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 44.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NAV | New | NAVISTAR INTL CORP NEW | $6,294,000 | – | 274,966 | +100.0% | 4.97% | – |
| RHI | Buy | ROBERT HALF INTL INC | $5,395,000 | +20.5% | 142,493 | +21.4% | 4.26% | -5.5% |
| FDC | Buy | FIRST DATA CORP NEW | $4,228,000 | +36.4% | 321,300 | +14.8% | 3.34% | +7.0% |
| ANTM | Buy | ANTHEM INC | $3,697,000 | +44.4% | 29,500 | +51.3% | 2.92% | +13.2% |
| WFTIQ | Buy | WEATHERFORD INTL PLC | $3,652,000 | +32.9% | 649,911 | +31.2% | 2.88% | +4.2% |
| WLH | Buy | LYON WILLIAM HOMEScl a new | $3,228,000 | +28.4% | 174,000 | +11.5% | 2.55% | +0.7% |
| RLGY | Buy | REALOGY HLDGS CORP | $3,188,000 | +3.4% | 123,279 | +16.0% | 2.52% | -18.9% |
| AIGWS | New | AMERICAN INTL GROUP INC*w exp 01/19/202 | $2,845,000 | – | 134,197 | +100.0% | 2.25% | – |
| WU | Buy | WESTERN UN CO | $2,680,000 | +51.9% | 128,700 | +39.9% | 2.12% | +19.2% |
| HAR | Buy | HARMAN INTL INDS INC | $2,677,000 | +38.1% | 31,700 | +17.4% | 2.11% | +8.3% |
| VRX | Buy | VALEANT PHARMACEUTICALS INTL | $2,585,000 | +122.1% | 105,300 | +82.2% | 2.04% | +74.2% |
| BACWSA | New | BANK AMER CORP*w exp 01/16/201 | $2,184,000 | – | 472,800 | +100.0% | 1.72% | – |
| SLCA | New | U S SILICA HLDGS INC | $2,030,000 | – | 43,606 | +100.0% | 1.60% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ROBERT HALF INTL INC | 36 | Q3 2023 | 4.8% |
| MOODYS CORP | 36 | Q3 2023 | 5.0% |
| BK OF AMERICA CORP | 36 | Q3 2023 | 5.5% |
| AMERICAN EXPRESS CO | 36 | Q3 2023 | 4.2% |
| MICROSOFT CORP | 36 | Q3 2023 | 4.1% |
| REALOGY HOLDINGS CORP | 36 | Q3 2023 | 5.0% |
| GOLDMAN SACHS GROUP INC | 36 | Q3 2023 | 3.2% |
| ALPHABET INC-CL A | 32 | Q3 2023 | 3.4% |
| ALPHABET INC-CL C | 31 | Q3 2023 | 2.5% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 6.8% |
View Stanley Capital Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Stanley Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.